In March, AACR's journals editors highlighted studies on the development of pediatric leukemia, the use of low-dose tamoxifen, and...
The AACR-Women in Cancer Research constituency group celebrates its 25th anniversary this year.
Researchers at the Blood Cancer Discovery Symposium presented data on multidrug resistance and clinical trial design.
Cody Wolf was one of 19 young scientists who visited Washington for AACR's Early-career Hill Day.
Four of the 2023 GSITA recipients explain how the program has benefited their careers.
Event cochair Dr. Michael Caligiuri shares how attendees can form connections to take science from bench to market.
Lobular breast cancer accounts for 15% of all breast cancer cases, but it is understudied.
Researchers are examining the gut microbiome to find better ways to diagnose and manage colorectal cancer.
February’s selections include a modified Zika virus to treat cancer, insights into treatment resistance, and more.
This Trojan horse-like treatment strategy may help neutralize undruggable cancer drivers.
Researchers are finding early clinical success in developing more targeted treatments for bile duct cancer, also called cholangiocarcinoma.